Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.1B | 2.1B | 2.1B | 2.1B |
Cost of revenue | 956M | 956M | 917M | 944M |
Gross profit | 1.1B | 1.1B | 1.2B | 1.1B |
Operating expense | ||||
Research & development | 193M | 199M | 189M | 192M |
Selling general and admin | 769M | 784M | 701M | 701M |
Other operating expenses | — | — | — | — |
Operating income | 152M | 136M | 275M | 244M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 104M | 107M | 107M | 114M |
Other income expense | -11M | -16M | -1M | -34M |
Pretax income | 38M | 13M | 167M | 96M |
Tax provision | -99M | -17M | 45M | 7M |
Net income | 137M | 30M | 122M | 89M |
Basic EPS | 0.8 | 0.2 | 0.7 | 0.5 |
Diluted EPS | 0.8 | 0.2 | 0.7 | 0.5 |
Basic average shares | 173.7M | 173.4M | 173.4M | 173.2M |
Diluted average shares | 174.8M | 174.5M | 173.9M | 173.5M |
EBITDA | 271M | 270M | 407M | 343M |
Net income from continuing op. | 137M | 31M | 122M | 89M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |